|
|
||||||||
The Journal of Immunology, Vol 158, Issue 5 2318-2326, Copyright © 1997 by American Association of Immunologists
ARTICLES |
DN Irani, KI Lin and DE Griffin
Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
The unique immunologic environment of the central nervous system (CNS) regulates most local inflammatory responses. In some circumstances, however, immune-mediated injury to the brain can occur. To understand how lymphocytes are regulated within the CNS during an inflammatory response that does not produce immunopathology, we have studied T cells isolated from the brains of mice with Sindbis virus (SV) encephalitis. Even though they express activation markers, these T cells are arrested in the cell cycle and do not proliferate in vitro. Altered phosphorylation of the retinoblastoma gene product, a critical cell cycle regulator, appears to mediate this effect. Furthermore, while brain-derived T cells generate IFN-gamma, IL-4, and IL-10, these T cells are deficient in IL-2 production compared with peripheral T cells. This pattern of cytokine production occurs in cells that do not activate NF-kappaB normally. When T cells producing both IL-2 and IFN- gamma are adoptively transferred into SV-infected mice, some of these cells traffic into the brain. Those that enter the brain selectively down-regulate IL-2 production over time. Since normal brain lipids can inhibit IL-2 production and T cell proliferation in vitro, these substances may mediate these same effects in vivo. Collectively, these data show that the local environment of the CNS during SV encephalitis exerts a complex regulatory effect on T cells that are recruited into the brain. We speculate that this effect serves to prevent excessive local T cell reactivity. Whether and how this regulation might fail in the setting of autoimmune neurologic disease remains to be explored.
This article has been cited by other articles:
![]() |
C. Ling, M. Sandor, M. Suresh, and Z. Fabry Traumatic Injury and the Presence of Antigen Differentially Contribute to T-Cell Recruitment in the CNS J. Neurosci., January 18, 2006; 26(3): 731 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C.-J. Cheeran, S. Hu, W. S. Sheng, P. K. Peterson, and J. R. Lokensgard CXCL10 Production from Cytomegalovirus-Stimulated Microglia Is Regulated by both Human and Viral Interleukin-10 J. Virol., April 15, 2003; 77(8): 4502 - 4515. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Marten, S. A. Stohlman, J. Zhou, and C. C. Bergmann Kinetics of Virus-Specific CD8+-T-Cell Expansion and Trafficking following Central Nervous System Infection J. Virol., February 15, 2003; 77(4): 2775 - 2778. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Belnoue, M. Kayibanda, A. M. Vigario, J.-C. Deschemin, N. v. Rooijen, M. Viguier, G. Snounou, and L. Renia On the Pathogenic Role of Brain-Sequestered {alpha}{beta} CD8+ T Cells in Experimental Cerebral Malaria J. Immunol., December 1, 2002; 169(11): 6369 - 6375. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhu, L. Luo, Y. Chen, D. W. Paty, and M. S. Cynader Intrathecal Fas Ligand Infusion Strengthens Immunoprivilege of Central Nervous System and Suppresses Experimental Autoimmune Encephalomyelitis J. Immunol., August 1, 2002; 169(3): 1561 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schluter, T. Meyer, L.-Y. Kwok, M. Montesinos-Rongen, S. Lutjen, A. Strack, M. L. Schmitz, and M. Deckert Phenotype and Regulation of Persistent Intracerebral T Cells in Murine Toxoplasma Encephalitis J. Immunol., July 1, 2002; 169(1): 315 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Jones, D. M. Basso, A. Sodhi, J. Z. Pan, R. P. Hart, R. C. MacCallum, S. Lee, C. C. Whitacre, and P. G. Popovich Pathological CNS Autoimmune Disease Triggered by Traumatic Spinal Cord Injury: Implications for Autoimmune Vaccine Therapy J. Neurosci., April 1, 2002; 22(7): 2690 - 2700. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Matthews, S. R. Weiss, M. J. Shlomchik, L. G. Hannum, J. L. Gombold, and Y. Paterson Antibody Is Required for Clearance of Infectious Murine Hepatitis Virus A59 from the Central Nervous System, But Not the Liver J. Immunol., November 1, 2001; 167(9): 5254 - 5263. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Liu and T. J. Chambers Yellow Fever Virus Encephalitis: Properties of the Brain-Associated T-Cell Response during Virus Clearance in Normal and Gamma Interferon-Deficient Mice and Requirement for CD4+ Lymphocytes J. Virol., March 1, 2001; 75(5): 2107 - 2118. [Abstract] [Full Text] |
||||
![]() |
M. Montesinos-Rongen, R. Kuppers, D. Schluter, T. Spieker, D. Van Roost, C. Schaller, G. Reifenberger, O. D. Wiestler, and M. Deckert-Schluter Primary Central Nervous System Lymphomas Are Derived from Germinal-Center B Cells and Show a Preferential Usage of the V4-34 Gene Segment Am. J. Pathol., December 1, 1999; 155(6): 2077 - 2086. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. A. MacDonald, A. R. Pettit, C. Quinn, G. J. Thomas, and R. Thomas Resistance of Rheumatoid Synovial Dendritic Cells to the Immunosuppressive Effects of IL-10 J. Immunol., November 15, 1999; 163(10): 5599 - 5607. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Bergmann, J. D. Altman, D. Hinton, and S. A. Stohlman Inverted Immunodominance and Impaired Cytolytic Function of CD8+ T Cells During Viral Persistence in the Central Nervous System J. Immunol., September 15, 1999; 163(6): 3379 - 3387. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. DerSimonian, L. Pan, C. Yatko, A. Rodrigue-Way, E. Johnson, and A. S. B. Edge Human Anti-Porcine T Cell Response: Blocking with Anti-Class I Antibody Leads to Hyporesponsiveness and a Switch in Cytokine Production J. Immunol., June 15, 1999; 162(12): 6993 - 7001. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Carson, C. R. Reilly, J. G. Sutcliffe, and D. Lo Disproportionate Recruitment of CD8+ T Cells into the Central Nervous System by Professional Antigen-Presenting Cells Am. J. Pathol., February 1, 1999; 154(2): 481 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Irani The Susceptibility of Mice to Immune-Mediated Neurologic Disease Correlates with the Degree to Which Their Lymphocytes Resist the Effects of Brain-Derived Gangliosides J. Immunol., September 15, 1998; 161(6): 2746 - 2752. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bauer, M. Bradl, W. F. Hickey, S. Forss-Petter, H. Breitschopf, C. Linington, H. Wekerle, and H. Lassmann T-Cell Apoptosis in Inflammatory Brain Lesions : Destruction of T Cells Does Not Depend on Antigen Recognition Am. J. Pathol., September 1, 1998; 153(3): 715 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Stalder, M. J. Carson, A. Pagenstecher, V. C. Asensio, C. Kincaid, M. Benedict, H. C. Powell, E. Masliah, and I. L. Campbell Late-Onset Chronic Inflammatory Encephalopathy in Immune-Competent and Severe Combined Immune-Deficient (SCID) Mice with Astrocyte-Targeted Expression of Tumor Necrosis Factor Am. J. Pathol., September 1, 1998; 153(3): 767 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Stohlman, C. C. Bergmann, M. T. Lin, D. J. Cua, and D. R. Hinton CTL Effector Function Within the Central Nervous System Requires CD4+ T Cells J. Immunol., March 15, 1998; 160(6): 2896 - 2904. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |